Health Conditions

Upper Respiratory Health

Other NamesAcute Coryza

Natural Remedies10

Ingredients123

Table of contents

Other Names

Acute CoryzaAcute LaryngitisAcute NasopharyngitisAcute Obstructive Laryngitis (Croup)Acute PharyngitisAcute Respiratory InfectionAcute SinusitisAcute TonsillitisAcute Upper Respiratory InfectionAcute Upper Respiratory Infections (ICD-10 J00–J06)Common ColdDisease of Upper Respiratory Tract, Unspecified (ICD-10 J39.9)Diseases of the Upper Respiratory TractDisorder of Upper Respiratory SystemEpiglottitisLaryngitisLaryngotracheitisNasopharyngitisOther Diseases of Upper Respiratory Tract (ICD-10 J30–J39)Otitis MediaPharyngitisRespiratory Tract Infection (RTI)Respiratory Tract Infections (MeSH D012141)RhinitisRhinopharyngitisRhinosinusitisSinusitisSupraglottitisTonsillitisTracheitisUpper Airway DiseaseUpper Airway InfectionUpper Respiratory IllnessUpper Respiratory Infection (URI)Upper Respiratory System DiseaseUpper Respiratory Tract HealthUpper Respiratory Tract Infection (URTI)URIURTIURTI (Upper Respiratory Tract Infection)

Synopsis

Upper Respiratory Health

Definition, Anatomy, and Clinical Presentation

The upper respiratory system refers to the nose, nasal cavities, sinuses, pharynx, and larynx. The demarcation between the upper and lower respiratory tracts is the vocal cords. The upper respiratory tract includes interconnected structures above the vocal cords — the nasopharynx, larynx, Eustachian tube, middle ear space, and sinuses — which play a crucial role in respiratory virus infections and house significant lymphoid tissue such as the tonsils and adenoids.

The upper respiratory tract comprises several key anatomical structures, each with specialized functions. The nose and nasal cavity serve as the primary entrance for air into the respiratory system; the nasal cavity is lined with a mucous membrane containing cilia and blood vessels that warm, humidify, and filter incoming air. The paranasal sinuses are air-filled spaces within the bones surrounding the nasal cavity; the maxillary, frontal, ethmoid, and sphenoid sinuses help reduce the weight of the skull, produce mucus, and contribute to voice resonance. The nasopharynx contains the adenoids (pharyngeal tonsils), which are part of the immune system and help protect against infections.

The anatomy of the upper respiratory tract contains several structures that help rid the system of particles and pathogens. The nasal cavity has a mucociliary lining similar to that of the lower respiratory tract; the inside of the nose is lined with hairs that filter larger particles. The turbinate bones ("baffle plates") are covered with mucus that collects particles not filtered by nasal hairs; these baffle plates cause inhaled air to swirl, forcing particles into contact with the mucus covering the nasal passages.

An upper respiratory tract infection (URTI) is a viral or bacterial infection that affects the nasal passages, sinuses, pharynx, or larynx, typically causing symptoms such as congestion, runny nose, sore throat, cough, and fever. Acute upper respiratory infections include the common cold, pharyngitis, epiglottitis, and laryngotracheitis; these infections are usually benign, transitory, and self-limited, although epiglottitis and laryngotracheitis can be serious diseases in children and young infants.

Depending on which part of the upper respiratory tract is affected, these infections may have different types, such as rhinitis, sinusitis, pharyngitis, epiglottitis, laryngitis, and others. URIs range from the common cold — typically a mild, self-limited, catarrhal syndrome of the nasopharynx — to life-threatening illnesses such as epiglottitis.

URIs involve direct invasion of the mucosa lining the upper airway. Inoculation of bacteria or viruses occurs when a person's hand comes in contact with pathogens and the person then touches the nose or mouth, or when a person directly inhales respiratory droplets from an infected person who is coughing or sneezing. After inoculation, viruses and bacteria encounter several barriers, including physical, mechanical, humoral, and cellular immune defenses.

Causative Agents and Pathogens

URIs are usually caused by viruses responsible for the common cold or flu; the most common are rhinovirus, influenza virus, respiratory syncytial virus (RSV), parainfluenza virus, and adenovirus. Etiologic agents associated with URI include viruses, bacteria, mycoplasma, and fungi. Some URIs, like strep throat or some cases of sinusitis, are bacterial infections.

Epidemiology and Global Burden

Upper respiratory infections are the leading cause of acute disease incidence worldwide and contribute to a substantial health-care burden. In 2021, the global number of new episodes of upper RTIs was 12.8 billion and accounted for 19,600 deaths.

Among all age groups, children under five years old had the highest incidence and DALY rates of URIs. A previous review highlighted that adults had an average of two to four episodes of common cold annually, whereas children might have as many as six to eight episodes. The highest URI-related mortality is found in the elderly and in children under five years old, consistent with findings that URIs are associated with increased risk of lower respiratory complications and deaths in those age groups.

Respiratory infections are more common in the fall and winter when school starts and indoor crowding facilitates transmission. A seasonal variation is present with more episodes in winter and fall, and on average, episodes of common colds last around 10 days.

Contributing and Associated Factors

Host and Demographic Factors

Upper respiratory infections affect patients of all ages, with severity influenced by demographics, comorbidities, and immunosuppression. Significant predictors of admission include COPD, asthma, heart failure, ischemic heart disease, hypertension, diabetes, chronic kidney disease, and immunodeficiency — even after adjusting for confounding variables. Clinical risk factors, particularly cardiopulmonary, metabolic, and immunological comorbidities, are associated with severe outcomes among multiple upper respiratory viruses.

Patients with suboptimal humoral and phagocytic immune function are at increased risk for contracting a URI and for a severe or prolonged course of disease. Inflammation (chronic or acute) from allergy predisposes to URI; children with allergy are particularly subject to frequent URIs.

Environmental and Exposure Factors

The Global Burden of Disease 2019 study assessed four risk factors for URI-related mortality and DALYs; among those, the leading one was low birth weight, the second was short gestation, and others included household air pollution from solid fuels and ambient particulate matter pollution.

Exposure to low temperature increases the occurrence of RTIs in urban areas, and high population density further increases the infection risk. Weather parameters — such as temperature, humidity, wind, and solar radiation — may independently or in interaction relate to contracting an RTI, because weather could influence the stability of viral pathogens in droplets and aerosols or alter the host airway defense and human behavior (degree of outdoor exposure).

Person-to-person spread of viruses accounts for most URIs. Household and child care settings can serve as reservoirs for infection.

Lifestyle-Related Factors

Various factors influence the risk of URTI, including physiological stress (i.e., exercise), psychological stress, sleep, travel, nutrition, and pathogen exposure. Psychological stress has been shown to influence the immune system, increasing susceptibility to respiratory infections. Too much life stress has been proven to be a major factor in decreasing body defenses; subjects who have undergone major life stressors have been shown to be more prone to the common cold.

Nutrients Studied in Relation to Upper Respiratory Health

Vitamin C (Ascorbic Acid)

Traditional Use

Vitamin C has been proposed for treating respiratory infections since it was isolated in the 1930s. It became particularly popular in the 1970s when Nobel laureate Linus Pauling concluded from earlier placebo-controlled trials that vitamin C would prevent and alleviate the common cold.

Scientific Evidence

Regular ingestion of vitamin C had no effect on common cold incidence in the ordinary population, based on 29 trial comparisons involving 11,306 participants. However, effects on duration are more consistently observed. The Cochrane review identified 31 comparisons examining the effect of regular vitamin C supplementation of at least 0.2 g/day on 9,745 episodes of respiratory virus infections. In adults, the duration of colds was reduced by 7.7% (95% CI: 3.7%–11.8%, P = 0.00018) and in children by 14.2% (95% CI: 7.3%–21.1%, P = 0.000053). These findings indicate that vitamin C has physiological effects, though the review did not demonstrate treatment effects on virus infections that had already started.

Based on two trials that compared two different vitamin C doses in separate trial arms, a dose-response relationship was indicated, with a prediction that doses of 6–8 g/day may shorten viral upper respiratory infections by some 20%.

In trials with participants exposed to short periods of extreme physical stress (including marathon runners and skiers), supplementation with vitamin C (0.6–1.0 g/day) halved the common cold risk; results suggest that vitamin C supplementation may be beneficial for some subjects doing heavy exercise who have problems with frequent upper respiratory infections. Regular supplementation (1 to 2 g/day) has shown that vitamin C may reduce the duration (in adults by 8%, in children by 14%) and the severity of the common cold.

Evidence strength: Moderate for reduction in duration with prophylactic supplementation; evidence is strongest in physically stressed populations. No significant effect on cold incidence in the general population. Evidence for therapeutic (treatment-phase) use is weak.

Zinc

Traditional Use

Interest in zinc lozenges for common cold treatment started from the serendipitous observation that the cold symptoms of a 3-year-old girl with leukemia disappeared within a few hours when she allowed a zinc tablet to slowly dissolve in her mouth instead of swallowing it whole. The benefit appeared to be derived from dissolving (rather than swallowing) the tablet, implying that zinc may have local effects in the oropharyngeal region. This observation led to a randomized controlled trial that found zinc gluconate lozenges significantly shortened colds, with a rate ratio of recovery of 3.5 (95% CI: 1.8–6.7) compared to placebo.

Scientific Evidence

In seven RCTs, zinc acetate and zinc gluconate lozenges containing more than 75 mg/day of elemental zinc shortened common cold duration on average by 33% (95% CI: 21%–45%, P = 10⁻⁷). In three zinc acetate lozenge trials, the rate of recovery from the common cold increased with a rate ratio of 3.1 (95% CI: 2.1–4.7).

Five trials used zinc doses of 80–92 mg/day and reduced common cold duration by 33%; two trials used zinc doses of 192–207 mg/day and found an effect of 35%. When pooling zinc lozenge trials, zinc lozenges shortened colds in adults with a ratio of means of 0.63, that is, by 37% (95% CI: 27%–46%; P = 10⁻⁹).

Most zinc studies (17 out of 34) evaluated the effectiveness of zinc administered as lozenges in acetate, gluconate, and orotate forms, with gluconate lozenges being the most common. There is concern about the potential for permanent anosmia from intranasal zinc.

Evidence strength: Moderate-to-strong for zinc lozenges (particularly acetate form, >75 mg/day elemental zinc) shortening cold duration in adults. Intranasal forms are associated with safety concerns and are not supported. The 2024 Cochrane review found heterogeneous results across different zinc formulations, and most studies carried unclear or high risk of bias in at least one domain.

Vitamin D

Traditional Use

Vitamin D has not been part of a prominent traditional herbal or folk medicine tradition for respiratory infections specifically, but its role in immune regulation through sunshine and diet has long been recognized empirically. The scientific investigation of its role in respiratory infections is a modern development.

Scientific Evidence

A 2017 meta-analysis of data from 25 randomised controlled trials (RCTs) of vitamin D supplementation for the prevention of acute respiratory infections revealed a protective effect of this intervention. A subsequent analysis included 43 RCTs with 49,320 participants. One subgroup analysis revealed that supplementation using doses less than 800 IU/day showed a significant preventive effect (adjusted odds ratio: 0.80, 95% CI: 0.68–0.94); another noted that doses of 400–1,000 IU/day exerted a preventive effect (RR: 0.70, 95% CI: 0.55–0.89).

For prevention, some trials reported reductions in the incidence of respiratory infections, particularly with daily supplementation or in vitamin D-deficient populations, whereas others observed no significant effect. For treatment, RCTs examining vitamin D as adjunctive therapy in hospitalized children with acute infections produced divergent results, with some suggesting shorter illness duration and others showing no meaningful clinical benefit. Existing reviews have underscored the variability in trial outcomes, resulting in ongoing uncertainty about the preventive and therapeutic role of vitamin D.

Evidence strength: Moderate for prevention, particularly with daily (rather than bolus) dosing and in vitamin D-deficient populations. Overall evidence is mixed and heterogeneous across trials. Evidence for treatment of active infection is preliminary and inconsistent.

Herbs and Natural Ingredients Studied in Relation to Upper Respiratory Health

Echinacea Species

Traditional Use

Echinacea preparations are commonly used to prevent and treat upper respiratory tract infections. Various species — principally Echinacea purpurea, E. angustifolia, and E. pallida — have been used in North American indigenous medicine for centuries and later adopted widely in European herbal practice, typically as expressed juice, dried extracts, or tinctures.

Scientific Evidence

A 2019 systematic review and meta-analysis (David & Cunningham) presented evidence that echinacea might have a preventative effect on the incidence of upper respiratory tract infections, but whether this effect is clinically meaningful is debatable. No evidence was found for an effect on the duration of URTIs. Regarding safety, no risk was apparent in the short term. The strength of these conclusions is limited by the risk of selective reporting and methodological heterogeneity.

Based on available results, users of echinacea can be assured that preparations are safe to consume in the short term; however, they should not be confident that commercially available remedies are likely to shorten the duration or effectively prevent URTI.

The most relevant potential adverse effect of echinacea preparations reported is allergic reactions.

Evidence strength: Preliminary to weak. A possible preventive effect on incidence has been suggested, but clinical significance is uncertain and no effect on duration is established. Heterogeneity of preparations studied (species, part of plant, dose, formulation) makes interpretation difficult.

Black Elderberry (Sambucus nigra)

Traditional Use

The Sambucus nigra plant belongs to the Adoxaceae family and is indigenous to Europe, Asia, and North Africa. Historically, the flower and berry of the Elder plant have been used in herbal preparations for the treatment of the common cold and flu. Native to northern Europe, the elderberry has a centuries-long history of medicinal use.

Scientific Evidence

The berries of the black elder plant have demonstrated antiviral activity against certain viruses which experience an increase in incidence during the winter months, including the common cold and influenza, in both in-vitro and in-vivo models. Elderberries contain many active chemicals, including anthocyanins (primarily cyanidin 3-glucoside and cyanidin 3-sambubioside), which have been shown to boost immune function and exhibit anti-viral effects.

Collectively, evidence from five clinical studies involving 936 adults indicates that mono-herbal preparations of Sambucus nigra berry, when taken within 48 hours of the onset of acute respiratory viral infection, may reduce the duration and severity of common cold and influenza symptoms in adults.

A 2019 meta-analysis of 180 participants found that supplementation with elderberry substantially reduced upper respiratory symptoms. Some preliminary research suggests that elderberry may relieve symptoms of flu, colds, or other upper respiratory infections.

Raw or unripe elderberries and other parts of the elder tree, such as the leaves and stem, contain poisonous cyanide-producing substances that can cause nausea, vomiting, and severe diarrhea; cooking eliminates this toxin.

Evidence strength: Preliminary to moderate. Clinical trials are small and heterogeneous, but results trend toward reduced symptom duration and severity when taken at symptom onset. Larger, better-controlled trials are needed. The NCCIH characterizes the evidence as preliminary.

Quercetin

Traditional Use

Quercetin is a flavonoid abundant in many food plants — particularly onions, apples, capers, and berries — and has been part of traditional diets rather than isolated supplemental use throughout history. It has been incorporated in various traditional plant-based remedies, though not as a recognized standalone herbal medicine in major traditional systems.

Scientific Evidence

Quercetin in culture with target cells and pathogens exerts anti-pathogenic activities against a wide variety of viruses and bacteria. A few small-scale human quercetin supplementation studies have produced conflicting results regarding quercetin's effects on URTI rates, and little is known regarding the appropriate human dose. A randomized, double-blinded, placebo-controlled trial measured the influence of two quercetin doses (500 and 1,000 mg/day) compared to placebo on URTI rates in a large community group (N = 1,002) of subjects varying widely in age (18–85 years), who ingested supplements for 12 weeks and logged URTI symptoms daily.

Evidence strength: Preliminary. In vitro and animal data are promising, but large, well-powered human RCT data are limited and results are mixed. No firm conclusion about quercetin's efficacy in preventing or treating URTI can yet be drawn from the clinical literature.

Probiotics

Traditional Use

Fermented foods containing live bacteria — including yogurt, kefir, sauerkraut, miso, and kimchi — have been consumed across cultures for millennia for general health, digestion, and disease prevention. The concept of gut-microbiome-mediated immune modulation is modern, but the dietary practice is ancient.

Scientific Evidence

A systematic review and meta-analysis searched PubMed, Web of Science, Embase, and the Cochrane Library through May 2020; RCTs comparing probiotics with placebo for the prevention of URTIs in adults were included. Six RCTs with 1,551 participants were analyzed. Compared with the placebo group, the probiotics group significantly reduced the incidence of URTI episodes (RR: 0.77; 95% CI: 0.68–0.87; P < 0.0001), the episode rate of URTIs (rate ratio: 0.72; 95% CI: 0.60–0.86; P = 0.0002), and the mean duration of one episode of URTI (MD: −2.66; 95% CI: −4.79 to −0.54; P = 0.01).

Low-quality evidence provides support that probiotics have potential efficacy for preventing URTI episodes in adults. More trials are required to confirm this conclusion. The adverse events of probiotics were mainly mild gastrointestinal symptoms.

A Cochrane review concluded that probiotics were better than placebo in reducing the number of participants experiencing episodes of acute URTI, the mean duration of an episode of acute URTI, antibiotic use, and cold-related school absence — indicating that probiotics may be more beneficial than placebo for preventing acute URTIs. However, the quality of the evidence was low or very low.

Evidence strength: Preliminary to low-quality. Multiple meta-analyses suggest benefit for URTI prevention and duration reduction, but marked heterogeneity between strains, doses, and populations, along with substantial risk of bias, limits firm conclusions. The optimal probiotic species, dose, and formulation remain undetermined.

Dietary and Lifestyle Factors

Physical Activity and Exercise

The relationship between exercise and upper respiratory tract infections may be modeled in the form of a "J" curve. Various epidemiological studies suggest that unusually heavy acute or chronic exercise is associated with an increased risk of URTI. Clinical data support the concept that heavy exertion increases the athlete's risk of URTI because of negative changes in immune function and elevation of the stress hormones, epinephrine and cortisol. On the other hand, there is growing evidence that moderate amounts of exercise may decrease one's risk of URTI through favorable changes in immune function without the negative attending effects of the stress hormones.

Moderate activity may enhance immune function, whereas prolonged, high-intensity exercise temporarily impairs immune competence. Athletes, when compared with lesser active individuals, experience a higher rate of URTI after training and competitions. In non-athletes, increasing physical activity is associated with a decreased risk of URTI.

A moderate exercise workload was associated with a 40–50% decrease in upper respiratory tract infections, while a 2–6-fold increase was identified among individuals consistently completing heavy exertion.

Sleep, Stress, and General Lifestyle

In conjunction with physical activity, the lifestyle behaviors that most support immune system health include adequate sleep, nutrition, hydration, and avoidance of excessive alcohol intake.

Psychological stress has been shown to influence the immune system, increasing susceptibility to respiratory infections. Too much life stress has been proven to be a major factor in decreasing body defenses; subjects who have undergone major life stressors have been shown to be more prone to the common cold.

Nutrition and Micronutrient Status

The current evidence of efficacy for zinc, vitamins D and C, and echinacea is considered sufficiently interesting that patients with the common cold may be encouraged to try them for preventing or treating colds, although further studies are needed.

Regular supplementation of vitamin C (1–2 g/day) and zinc (<100 mg/day) reduced the duration of the common cold by 8–14% and 33%, respectively, according to available data.

Iron deficiency may lead to impaired immune function, and although direct evidence for the prevention of URTIs via iron supplementation is limited, monitoring iron status is considered important for health reasons.

The upper respiratory system warms, humidifies, and filters air before it reaches the lungs while also providing immune protection through specialized tissues and mucociliary clearance mechanisms. The upper respiratory tract is susceptible to various conditions, including infections, allergies, and structural abnormalities that can impair its function.

Seasonal and Environmental Dietary Considerations

In European populations, adults have 2 to 5 infections annually; children typically present 6 to 12 colds per year, and rates of symptomatic infections increase in the elderly. These epidemiological patterns have driven interest in whether dietary modifications — particularly those aimed at supporting vitamin D status in winter months (through dietary sources such as fatty fish, egg yolks, and fortified foods) or supporting antioxidant intake year-round — may attenuate seasonal susceptibility, though direct evidence linking dietary patterns (as distinct from isolated nutrients) to URTI incidence remains limited in the peer-reviewed literature.

Summary of Evidence Strength by Intervention

Vitamin C (prophylactic, 1–2 g/day): Moderate evidence for modest reduction in cold duration; no reduction in incidence in the general population; stronger effects in physically stressed populations.
Zinc lozenges (>75 mg elemental zinc/day, acetate or gluconate form): Moderate-to-strong evidence for shortening cold duration in adults when started early; intranasal forms carry safety concerns.
Vitamin D (daily supplementation, 400–1,000 IU/day): Moderate evidence for ARI prevention, especially in deficient individuals; results heterogeneous across trials.
Echinacea: Weak-to-preliminary evidence for possible reduction in URTI incidence; no demonstrated effect on duration; evidence limited by methodological heterogeneity and preparation variability.
Elderberry (Sambucus nigra): Preliminary-to-moderate evidence from small trials suggesting reduced symptom duration and severity when initiated within 48 hours of symptom onset.
Quercetin: Primarily in-vitro and animal data; small, conflicting human trials; insufficient evidence for clinical recommendations.
Probiotics: Low-quality evidence suggesting reduced URTI incidence and duration; optimal species and dose unknown; results limited by heterogeneity and publication bias.
Moderate exercise: Epidemiological evidence supports a 40–50% reduction in URTI risk with moderate (but not excessive) physical activity.

References

Natural Remedies

Remedy 1

Raw Honey & Lemon Warm Drink: Honey contains antimicrobial compounds and bioactive phytochemicals that exert soothing effects on the upper respiratory tract, while lemon provides a natural source of vitamin C to support immune defense. Stir a tablespoon of raw honey and the juice of half a lemon into a cup of warm (not boiling) water and sip slowly, especially at the first sign of throat irritation or congestion.

Remedy 2

Elderberry Syrup: Black elderberry has long been studied for its potential to support the immune system and may help reduce the duration and severity of upper respiratory infections. Prepare or purchase a traditional elderberry syrup and take one tablespoon daily as a preventive measure, or two to three times daily at the onset of symptoms.

Remedy 3

Steam Inhalation with Eucalyptus or Peppermint: Inhaling steam infused with eucalyptus or peppermint essential oil may relieve nasal congestion; these oils are thought to have antimicrobial properties that benefit the respiratory system. Add two to three drops of eucalyptus or peppermint oil to a bowl of hot water, drape a towel over your head, and breathe deeply for five to ten minutes.

Remedy 4

Thyme Herbal Tea: Thyme contains a naturally occurring compound called thymol, which has strong antimicrobial properties, making it effective against bacterial infections of the throat and nasal passages. It is also recognized for its expectorant action — helping to clear catarrh and relieve coughs. Steep one to two teaspoons of fresh thyme leaves in boiling water for five to eight minutes, strain, and drink two to three cups per day.

Remedy 5

Mullein Leaf Tea: Mullein is a traditional respiratory tonic that helps open the airways, eases spasms and tightness, and soothes irritation and dryness in the upper respiratory tract. Steep one to two teaspoons of dried mullein leaf in hot water for ten to fifteen minutes, strain well to remove fine leaf hairs, and drink one to two cups daily.

Remedy 6

Garlic & Anti-Inflammatory Diet: Garlic helps combat respiratory infections due to its antiviral and antibacterial compounds, and a diet rich in fruits, vegetables, and omega-3 fatty acids supports lung function and reduces overall inflammation. Incorporate raw or lightly cooked garlic into daily meals and minimize pro-inflammatory foods such as refined carbohydrates, sugar, and processed foods in favor of whole, antioxidant-rich produce.

Remedy 7

Saltwater Nasal Rinse (Saline Irrigation): Rinsing the nasal passages with a warm saline solution helps flush out pathogens, thin excess mucus, and keep the mucous membranes of the upper respiratory tract moist and healthy. Dissolve a quarter to half a teaspoon of non-iodized salt in a cup of warm distilled or boiled water, then use a neti pot or saline squeeze bottle to gently irrigate each nostril once or twice daily.

Remedy 8

Prioritizing Rest & Quality Sleep: Adequate sleep is crucial for upper respiratory health because it allows the immune system to function optimally, supporting the body's natural defense and repair processes. Create a consistent sleep schedule, keep the bedroom cool and dark, and use a humidifier to add moisture to the air — dry indoor air can irritate and dry out nasal and throat membranes.

Remedy 9

Marshmallow Root Cold Infusion: Marshmallow root is a mucilage herb that produces a gel-like coating, protecting and soothing irritated mucous membranes and inflamed tissues throughout the respiratory tract, and can relieve a sore throat and dry, irritated airways. Place one to two tablespoons of dried marshmallow root in a cup of cold or room-temperature water, allow it to infuse for four to eight hours, strain, and sip throughout the day — cold infusion best preserves its soothing mucilage.

Remedy 10

Diaphragmatic Breathing & Gentle Movement: Pranayama-style breathing exercises and moderate activities like walking or gentle yoga help tone the muscles of the respiratory system, improve circulation, aid the clearance of congestion, and reduce stress-induced breathing difficulties. Practice slow, deep diaphragmatic breathing for five to ten minutes each morning — inhaling through the nose, expanding the belly, and exhaling fully — and incorporate a daily gentle walk to maintain healthy airflow and immune function.

Ingredients

These ingredients are often used in alternative medicine to support upper respiratory health.

ajwainScientific
Ajwain has clinically documented bronchodilatory effects in asthmatic patients (Boskabady 2007) and preclinical antitussive data (Boskabady 2005). Combined with antimicrobial activity against respiratory pathogens, it has scientifically characterized activity across multiple aspects of upper and lower respiratory health.
andrographisScientific
Andrographis paniculata has robust clinical evidence for URTI treatment. A DARE-assessed systematic review of 7 controlled trials (n=896) found it significantly superior to placebo for uncomplicated URTI symptom relief. A double-blind RCT of KalmCold (200 mg/day, n=223) showed significant improvement in all nine measured URTI symptoms by day 5 vs. placebo.
andrographolideScientific
Andrographolide is the principal diterpene lactone from Andrographis paniculata responsible for anti-URTI activity. It inhibits NF-κB-mediated inflammation, modulates immune responses, and has demonstrated antiviral activity against influenza and RSV. Clinical RCTs using andrographolide-standardized extracts show significant URTI symptom improvement.
arabinogalactanScientific
Clinical evidence, including a 199-person RCT over 12 weeks, demonstrates that larch arabinogalactan supplementation significantly reduced the incidence and number of participants affected by upper respiratory tract infections. Additional vaccine-response studies further support an immunostimulatory effect relevant to upper respiratory defence. Mechanistic data suggest NK cell enhancement and macrophage activation as contributing pathways.
aronia melanocarpaScientific
A randomized, double-blind, placebo-controlled trial in 61 adults prone to upper respiratory tract infections found that a blend containing Aronia melanocarpa significantly reduced URTI incidence over a 60-day period. In vitro studies confirm that Aronia juice inhibits influenza virus replication, including drug-resistant strains.
bacillus clausiiScientific
A pilot RCT in 80 children showed B. clausii significantly reduced both the number and duration of recurrent respiratory infections over a treatment and follow-up period. The gut-lung immune axis is proposed as the mechanism. Evidence is currently limited to small pilot studies, and larger confirmatory trials are needed.
beta-glucanScientific
Beta-glucans from yeast or mushrooms have clinical evidence from multiple RCTs for reducing URTI incidence, severity, and duration through activation of innate immune cells (macrophages, neutrophils) via Dectin-1 and complement receptors. Multiple trials in stressed populations show consistent reductions in cold frequency and sick days.
bifidobacterium animalisScientific
Clinical studies show that B. animalis subsp. lactis BB-12, often combined with L. rhamnosus GG, reduces the duration and severity of upper respiratory tract infections (URTI) in healthy adults and college students. A crossover RCT found participants receiving BB-12 had elevated NK-cell cytotoxicity and IL-2 secretion concurrently with fewer URTI days. BB-12 has also been linked to increased body resistance to common respiratory infections across multiple clinical studies.
bifidobacterium lactisScientific
Multiple clinical trials, including a large RCT with B. lactis Bl-04 and combination trials with B. lactis BB-12 and HN019, demonstrate that B. lactis supplementation reduces the risk, duration, or severity of upper respiratory tract infections. Effects are linked to enhanced NK-cell function, secretory IgA, and mucosal immunity.
bromelainScientific
Bromelain has been evaluated in clinical studies for chronic sinusitis and upper respiratory tract infections, demonstrating immunomodulatory, mucolytic, and anti-inflammatory effects on nasal mucosa. A case-control study found that adding a bromelain-containing supplement to standard sinusitis treatment improved nasal hyperemia, rhinorrhea, and inflammatory markers (WBC, IgE, CRP). It is used clinically in Europe as part of combination products for sinusitis.
camphor oilScientific
The PMC 2023 bibliometric review found clinical evidence for camphor/menthol compounds in upper respiratory infection symptom management, including cough suppression and congestion relief. Camphor is a recognized OTC ingredient in chest rubs and nasal decongestant products. The mechanism involves TRP channel modulation inhibiting respiratory reflexes.
cod liver oilScientific
Cod liver oil's vitamin D reduces susceptibility to respiratory tract infections by supporting innate and adaptive mucosal immunity. An observational study (HUNT study, Norway) found regular cod liver oil intake was associated with lower incidence of adult asthma. CLO's anti-inflammatory properties also modulate airway inflammation.
colostrumScientific
Bovine colostrum supplementation significantly reduces the incidence and duration of upper respiratory tract infections (URTIs). A 2016 meta-analysis of five RCTs found a 44% reduction in symptomatic URTI days and a 38% reduction in URTI episodes. Benefits extend beyond athletes to higher-risk non-athletic populations.
echinaceaScientific
Multiple systematic reviews and meta-analyses have evaluated Echinacea for upper respiratory tract infections. A 2019 meta-analysis found a risk ratio of 0.78 (95% CI 0.68–0.88) for URTI prevention. Evidence suggests modest benefit for early treatment and possible prevention of acute URIs. A Cochrane review (2014) also found some preparations reduced cold incidence and duration.
echinacea purpureaScientific
Echinacea purpurea is the most clinically studied Echinacea species for URTI. Randomized controlled trials demonstrate it reduces severity and duration of cold symptoms. A 2025 meta-analysis of 9 RCTs in children confirmed its efficacy for URTI treatment and prevention of otitis media complications.
EGCG (epigallocatechin gallate)Scientific
EGCG is the primary catechin in green tea responsible for antiviral activity against influenza, RSV, and other respiratory viruses. Green tea EGCG supplementation significantly reduced laboratory-confirmed influenza infections in a double-blind RCT of healthcare workers (n=197, OR 0.27). It inhibits viral neuraminidase, hemagglutinin, and RNA polymerase.
elderberryScientific
Black elderberry (Sambucus nigra) has clinical evidence from multiple RCTs and a 2019 meta-analysis (4 studies) finding significant reductions in upper respiratory symptom duration and severity vs. placebo. A Cochrane-methodology 2021 systematic review of 5 RCTs found elderberry may reduce cold and influenza duration, though evidence certainty is rated as low-to-uncertain.
eucalyptusScientific
Eucalyptus oil (1,8-cineole/eucalyptol) has Commission E and EMA approval for catarrhs of the upper respiratory tract. Clinical RCTs found oral cineole (200 mg 3×/day) significantly improved acute non-purulent sinusitis and bronchitis severity vs. placebo. It acts as a secretolytic, bronchospasmolytic, and antimicrobial agent.
european elderScientific
Elderberry is one of the most clinically studied botanicals for upper respiratory viral infections. RCT and meta-analytic evidence support reductions in duration and severity of upper respiratory symptoms. The EMA and German Commission E both recognize elderflower preparations for upper respiratory conditions. Evidence is stronger for influenza than for common cold.
fritillaryScientific
Fritillary is pharmacologically active against multiple mechanisms relevant to upper respiratory disease: antitussive, expectorant, antibacterial, and anti-inflammatory. It is used clinically in TCM for upper respiratory infections. Preclinical studies demonstrate inhibition of respiratory epithelial mucin production and reduction of inflammatory cytokines.
garlic bulbScientific
Garlic allicin has demonstrated in vitro antibacterial activity against major lung pathogens including Streptococcus pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus, including MDR strains. Traditional use across Chinese, Japanese, and North American indigenous cultures for respiratory conditions is also documented. Clinical RCT evidence for upper respiratory tract infections beyond the common cold is limited.
geraniumScientific
Pelargonium sidoides has robust clinical evidence for upper respiratory tract infections including cold, bronchitis, and sinusitis, backed by a Cochrane review and EMA regulatory approval. P. graveolens shows ethnobotanical and in vitro evidence for respiratory use including viral ACE2 inhibition.
ginsengScientific
North American ginseng (Panax quinquefolius, COLD-FX) has clinical evidence from double-blind RCTs showing significant reduction in cold incidence in elderly adults (10% vs. 22.8% in placebo, p=0.002). NCCIH cites inconsistent but supportive evidence for both Asian and North American ginseng for URTI prevention.
ginsenosidesScientific
Ginsenosides are the primary bioactive saponins of Panax ginseng and P. quinquefolius responsible for immunomodulatory effects relevant to URTI prevention. They enhance NK cell activity, T-cell proliferation, and interferon production. Clinical URTI evidence is primarily from COLD-FX (standardized North American ginseng) RCTs showing significant cold incidence reduction.
green chirettaScientific
Green chiretta has the most robust clinical evidence of any botanical for acute upper respiratory tract infections (URTIs). A mechanistic systematic review confirms immunomodulation, antiviral activity, and antipyretic effects underpinning this action. Both monotherapy and combination products reduce URTI symptom severity and duration in RCTs.
green teaScientific
Green tea catechins (primarily EGCG) have clinical evidence for reducing influenza and URTI incidence. A double-blind RCT (n=197 healthcare workers) found green tea catechin supplementation significantly reduced laboratory-confirmed influenza infection rates. EGCG inhibits influenza viral neuraminidase and hemagglutinin in preclinical studies.
honeyScientific
Honey has clinical RCT evidence for nocturnal cough in children with upper respiratory infections. A landmark 2007 RCT (n=105 children) found buckwheat honey significantly outperformed dextromethorphan and no treatment for URTI-related cough. WHO and multiple guidelines recognize honey as a low-cost option for childhood cough associated with URTI.
horseradishScientific
Multiple clinical studies have investigated a fixed combination of horseradish root and nasturtium (Angocin Anti-Infekt N) for acute sinusitis and bronchitis. A prospective cohort study in 1,649 adults found symptom reduction comparable to standard antibiotics for sinusitis and bronchitis, with fewer side effects. A randomised, double-blind, placebo-controlled phase IV trial further supported the product's efficacy for acute bronchitis. Evidence is for the combination product, not isolated horseradish.
lactobacillus caseiScientific
L. casei Shirota has been evaluated in RCTs for reducing the incidence and duration of upper respiratory tract infections (URTIs) in adults and children. A published RCT in healthy middle-aged office workers found that daily fermented milk with L. casei Shirota reduced URTI incidence and duration. A multi-strain formulation including L. casei 431 reduced URTI incidence in susceptible adults via increased IFN-γ and sIgA.
lactobacillus paracaseiScientific
L. paracasei strains have been studied in RCTs for upper respiratory tract infections (URTIs), including a study showing reduced URTI duration in elderly consuming L. paracasei N1115-supplemented yogurt, and the L. casei 431 RCT measuring upper respiratory symptom incidence and duration in 1,104 adults around influenza vaccination.
lactobacillus rhamnosusScientific
A 571-child double-blind RCT found LGG supplementation produced a 17% relative reduction in respiratory infections with complications and lower respiratory tract infections. L. rhamnosus D3189 reduced RSV shedding and modulated innate immune responses in nasal epithelial cells in vitro. A patent-protected RCT demonstrated fewer illness days and lower severity scores in the probiotic group versus placebo for upper respiratory tract infections.
lactobacillus salivariusScientific
Clinical and mechanistic evidence supports L. salivarius benefits for upper respiratory tract health, primarily through immune modulation and competitive exclusion of pathogens. L. salivarius PS7 has been developed specifically for prevention of recurrent acute otitis media and upper respiratory infections in children, with patent-documented clinical reduction in AOM episodes. Small-scale human trials suggest reduced incidence and duration of upper respiratory infections, especially in children and elderly.
lactoferrinScientific
A systematic review and meta-analysis of 25 human studies found that lactoferrin supplementation improved immune function and reduced systemic inflammation in the majority of trials, with several studies specifically addressing respiratory tract infection (RTI) outcomes. Evidence is strongest for reducing RTI incidence in select populations.
lactoperoxidaseScientific
Lactoperoxidase is secreted by airway mucosal glands into the respiratory surface liquid, where it forms part of the innate antimicrobial defense of the airways. The LPO/thiocyanate/H₂O₂ system in tracheal and bronchial epithelial cells has been shown to produce hypothiocyanite that inactivates respiratory bacteria and viruses. Evidence is from ex vivo and cell/tissue studies; there are no clinical intervention trials with exogenous LPO for upper respiratory conditions.
malabar nutScientific
Two published randomized clinical trials tested a combination product (KanJang) containing Adhatoda vasica leaf extract in patients with acute upper respiratory tract infections, showing significant improvement in coughing, mucus clearance, and nasal congestion. One trial was double-blind placebo-controlled; both are published in Phytomedicine.
menthol oilScientific
Menthol is clinically documented to improve subjective airflow sensation in nasal congestion and to reduce cough reflex via TRPM8 receptor activation. It is a recognized active ingredient in products approved for upper respiratory tract symptomatic relief.
monolaurinScientific
Monolaurin demonstrates in vitro activity against multiple enveloped respiratory viruses (influenza, coronaviruses, RSV). An unpublished safety study found nasal administration of 5% GML gel to 50 individuals produced no adverse effects, and prior macaque research showed nasal GML prevented SIV transmission. No completed human RCTs for upper respiratory infections exist.
NAC (N-acetyl cysteine)Scientific
N-Acetyl Cysteine (NAC) is approved in multiple countries as a mucolytic for respiratory conditions. It reduces mucus viscosity, has antiviral activity against influenza and RSV, and is recommended as supportive therapy for upper respiratory infections including chronic rhinosinusitis. A 2015 Cochrane review confirmed NAC reduces exacerbation rates in chronic bronchitis.
onionScientific
Onion and its bioactive constituents (quercetin, thiosulfinates, sulfur compounds) have documented effects on upper respiratory health, including bronchial relaxation, anti-inflammatory, and antimicrobial activity relevant to upper respiratory tract conditions. The 2021 PMC comprehensive review confirmed evidence across respiratory and immunological endpoints for A. cepa.
pelargoniumScientific
Pelargonium sidoides root extract (EPs 7630/Umckaloabo) has Cochrane-reviewed clinical evidence for acute respiratory tract infections. Multiple RCTs found it effective for bronchitis, sinusitis, tonsillopharyngitis, and the common cold. It has been approved for acute bronchitis treatment in Germany since 2005.
pistacia integerrima gallScientific
P. integerrima galls are among the most studied plants for respiratory conditions. Preclinical studies confirm bronchodilatory, mast-cell stabilizing, antihistaminic, and anti-inflammatory effects relevant to upper and lower respiratory health. Clinical observations in poly-herbal formulations report improvement in respiratory rate and prevention of respiratory attacks. The Springer 3 Biotech 2026 review provides the most up-to-date synthesis.
plantagoScientific
Plantago lanceolata is endorsed by the German Commission E and ESCOP for catarrh of the upper airways and inflammation of oral and pharyngeal mucosa. Clinical studies demonstrate anti-inflammatory, spasmolytic, and immunostimulant activity relevant to upper respiratory infections. ESCOP's open clinical study confirms efficacy in respiratory catarrh.
plantainScientific
Plantago lanceolata is officially used and pharmacopoeially recognized for upper respiratory tract infections including cough and pharyngeal inflammation. P. major extracts show anti-inflammatory, spasmolytic, and antimicrobial activity in the upper airways. Human trials and monograph-level recognition support this application.
privetScientific
In vitro studies show that secoiridoid constituents of Ligustrum lucidum, including oleuropein and ligulucisides, inhibit respiratory syncytial virus (RSV), parainfluenza type 3, and influenza A virus. Traditional use also includes treatment of respiratory tract infections. No human trials exist.
quercetinScientific
Quercetin has antiviral activity against influenza, RSV, and rhinoviruses in preclinical studies, and a double-blind RCT in athletes (n=40) found significant reduction in URTI episodes (1 vs. 9 in placebo). It inhibits viral neuraminidase, NF-κB signaling, and enhances interferon responses relevant to upper respiratory defense.
rose hipsScientific
Rose hips support upper respiratory health primarily through their high vitamin C content, which reduces the severity and duration of upper respiratory infections. Anti-inflammatory flavonoids, including quercetin, may soothe airway mucous membranes and exhibit antihistamine-like properties. Meta-analyses of vitamin C supplementation confirm 8–14% reduction in cold duration, directly applicable to rose hip's principal bioactive.
rosmarinic acidScientific
A published human clinical trial demonstrated that oral rosmarinic acid (50 mg or 200 mg/day for 21 days) significantly reduced symptoms of seasonal allergic rhinoconjunctivitis (SAR), decreased nasal neutrophil and eosinophil counts, and outperformed placebo. RA has also been documented in traditional use for upper respiratory complaints in Lamiaceae herbal medicine.
serratiopeptidaseScientific
Serratiopeptidase has demonstrated clinical benefit across multiple upper respiratory conditions including sinusitis, laryngitis, rhinitis, and ENT inflammation in general. The 1990 Mazzone et al. multicenter RCT (n=193) documented significant symptom improvement in acute or chronic ENT pathologies. Clinical use in upper respiratory conditions has been established in Japan and Europe for decades.
thymeScientific
Thyme (Thymus vulgaris) has Commission E and EMA approval for symptomatic relief of cough and upper respiratory catarrh. Multiple clinical trials of ivy/thyme combination preparations showed significant improvement in bronchitis severity. Its thymol and carvacrol components provide expectorant, spasmolytic, and antimicrobial actions.
thymusScientific
Thymus vulgaris is formally approved by the German Commission E and recognised by the EMA HMPC and ESCOP for catarrh of the upper respiratory tract and productive cough associated with colds. Clinical trial evidence from multiple double-blind RCTs supports thyme-containing preparations for upper respiratory tract infections with productive cough.
vitamin CScientific
Vitamin C has been extensively studied for the common cold via Cochrane meta-analysis. Regular supplementation modestly reduces cold duration (8% in adults, 14% in children) and severity but does not prevent colds in the general population. Populations under heavy physical or cold stress show greater preventive benefit (RR ~0.48).
vitamin DScientific
Vitamin D has robust evidence from a landmark 2017 BMJ meta-analysis (25 RCTs, n=11,321) finding supplementation significantly reduced acute respiratory infection incidence. It induces antimicrobial peptide production (cathelicidin/LL-37) against respiratory pathogens and modulates immune inflammatory responses during URTI.
vitamin D3Scientific
Vitamin D3 (cholecalciferol) is the most bioavailable form of vitamin D used in URTI clinical research. The landmark 2017 BMJ meta-analysis (25 RCTs, n=11,321) found D3 supplementation significantly reduced acute respiratory infection incidence, with greatest benefit in severely deficient individuals using daily/weekly dosing.
zincScientific
Zinc lozenges are among the best-evidenced interventions for reducing common cold duration. NCCIH and a 2015 meta-analysis (3 RCTs, 80–92 mg/day zinc acetate) confirm significant reductions in nasal discharge (34%), nasal congestion (37%), cough (46%), and hoarseness (43%). Zinc lozenges should be started within 24 hours of symptom onset.
abies spectabilisTraditional
Mouth and upper respiratory tract disorders are among the documented traditional indications of A. spectabilis in Himalayan ethnobotany. The leaves' expectorant, antimicrobial, and antitussive properties support this application.
allicinTraditional
Allicin, the principal antimicrobial compound of garlic, was 'highly effective in one small trial' for cold prevention per NCCIH. It demonstrates antimicrobial and antiviral activity against influenza viruses and rhinoviruses in preclinical studies. Clinical evidence is limited to a single RCT requiring replication.
alliinTraditional
Alliin is the stable sulfur-containing precursor in garlic that enzymatically converts to allicin upon crushing. As the quality marker for allicin-yielding garlic supplements and as the precursor to garlic's antimicrobial active compounds, alliin is relevant to garlic's traditional and clinical use for upper respiratory infections.
allspiceTraditional
Allspice is documented in traditional herbalism for chest infections, respiratory congestion, and coughs. Its volatile oils have expectorant and antimicrobial properties. In vitro research confirms antimicrobial activity against respiratory pathogens. No human trials exist.
aster rootTraditional
In Western folk herbalism and TCM, Aster root has been used for upper respiratory infections, throat irritation, and acute cough with phlegm. TCM texts document use dating back over 2,000 years for clearing lung qi and alleviating acute respiratory symptoms. Scientific evidence supporting upper respiratory efficacy in humans is lacking.
astragalosideTraditional
Astragaloside is a key saponin constituent of Astragalus membranaceus responsible for immunomodulatory activity relevant to URTI prevention. It activates T lymphocytes, NK cells, and macrophages, and contributes to astragalus's traditional role as an immune tonic for preventing upper respiratory infections in TCM.
astragalusTraditional
Astragalus (Astragalus membranaceus) is a foundational herb in Traditional Chinese Medicine used for millennia to prevent upper respiratory infections via immunomodulation. Multiple immunological studies show enhanced immunoglobulin production and T-cell restoration. No direct human URTI RCTs have been completed, but it is widely used preventively.
baicalinTraditional
Baicalin, the primary flavonoid from Baikal skullcap (Scutellaria baicalensis), is a component of Shuanghuanglian widely used in Chinese hospitals for URTI. It demonstrates antiviral activity against influenza, RSV, and parainfluenza viruses, and anti-inflammatory activity via NF-κB inhibition.
baikal skullcapTraditional
Baikal skullcap (Scutellaria baicalensis; Huang Qin) is a cornerstone TCM herb for acute URTI with fever and inflammation. Its active compounds (baicalin, baicalein, wogonin) inhibit influenza, RSV, and parainfluenza viruses and suppress pro-inflammatory signaling. It is a key component of Shuanghuanglian used in Chinese hospitals for URTI.
balloon flowerTraditional
Balloon flower (Platycodon grandiflorum) root is the common English name for the TCM herb Jie Geng, used for cough, phlegm, and sore throat in upper respiratory conditions. Its saponins provide expectorant, anti-inflammatory, and antiviral activity. It features in multiple classical URTI formulas such as Jie Geng Tang and Sang Ju Yin.
barberryTraditional
Barberry has traditional use for upper respiratory tract conditions including sinusitis, nasal congestion, and bronchitis, attributed to berberine's antimicrobial properties and anti-inflammatory effects on mucous membranes. Multiple herbal references document this use across traditions.
bayberryTraditional
Bayberry was traditionally used for upper respiratory conditions including laryngitis, sore throat, and catarrhal states of the upper airways. It was a key ingredient in composition powder used for these conditions. TCM also documents its use for laryngitis. No clinical evidence exists.
bee propolisTraditional
Bee propolis has traditional use and preclinical/clinical evidence for upper respiratory infections. Its polyphenolic constituents (CAPE, galangin, quercetin) demonstrate antimicrobial, antiviral, and anti-inflammatory activity against respiratory pathogens. A 2023 clinical study found it recommended as supportive therapy for chronic URTI including rhinosinusitis.
black spruceTraditional
Black spruce is traditionally used for upper respiratory complaints including colds, sinus congestion, catarrh, and pharyngitis. The British Herbal Pharmacopoeia supports its use for pharyngitis, and aromatherapy sources document its decongestant and antiseptic properties for the upper respiratory tract.
bonesetTraditional
Boneset has a well-documented traditional role in supporting the upper respiratory tract during acute infections, including nasopharyngeal catarrh, colds, coughs, and allergic rhinitis. Herbal Reality's monograph records its use for these conditions as a hot infusion acting via diaphoretic and expectorant mechanisms. A 19th-century medical text confirmed its use for catarrh. No clinical trials for upper respiratory tract conditions specifically have been conducted.
cajuputTraditional
Cajuput oil is deeply embedded in Southeast Asian, Australian Aboriginal, and European traditional medicine as a respiratory remedy, used by steam inhalation and chest application for coughs, colds, bronchitis, and asthma. Its 1,8-cineole content provides pharmacologically documented expectorant, mucolytic, and anti-inflammatory properties relevant to upper respiratory health. Direct cajuput human clinical evidence is absent.
cayenne pepperTraditional
Cayenne pepper has extensive traditional use for cough, bronchitis, sore throat, and respiratory congestion. Capsaicin's irritant properties stimulate mucosal secretions and airway clearing. Clinical evidence for these specific upper respiratory indications is limited, though nasal capsaicin has been evaluated for rhinitis.
chrysanthemumTraditional
Chrysanthemum is a classic TCM herb for the Lung meridian and is used for cough, congestion, and respiratory infections. It is listed in the Pharmacopoeia of the People's Republic of China as connected to the Lung channel. In vitro studies show antibacterial and anti-inflammatory properties relevant to respiratory health.
cloveTraditional
Clove and eugenol have documented traditional and pharmacological use for upper respiratory tract infections and mucosal inflammation. A PMC review confirms eugenol is included in medications for upper respiratory mucosa inflammation.
coltsfootTraditional
Coltsfoot is one of the most historically prominent European and Chinese herbal remedies for upper respiratory tract complaints including cough, hoarseness, laryngitis, nasal congestion, and airway irritation. Its mucilage, expectorant, and antispasmodic properties are widely described. Clinical evidence is absent.
elecampaneTraditional
Upper respiratory support—particularly for bronchitis, whooping cough, and cough with excessive mucus—represents elecampane's primary and most consistently documented traditional indication, recorded in the British Herbal Pharmacopoeia, BHP, ancient Greek texts, Ayurveda, and TCM. Evidence is traditional with mechanistic in vitro support but no clinical trials.
ferula assafoetidaTraditional
Asafoetida is one of the most widely documented traditional remedies for upper and lower respiratory conditions, including bronchitis, asthma, whooping cough, and influenza, across Ayurvedic, Unani, European, and Middle Eastern medicine. Its expectorant mechanism involves elimination of volatile oil through the lungs.
forsythiaTraditional
Forsythia suspensa fruit (Lian Qiao) is a principal TCM herb for upper respiratory infections with fever, sore throat, and inflammation. A key component of Shuanghuanglian (used in Chinese hospitals for URTI) and classical Yin Qiao San formula, its active forsythia glycosides show antiviral activity against influenza and RSV.
garlicTraditional
Garlic (Allium sativum) has been used globally for millennia for respiratory infections. NCCIH cites one small trial where allicin was highly effective for cold prevention. A Cochrane review found insufficient evidence from trials (only one acceptable RCT showed 63% reduction in cold incidence), though preclinical evidence for allicin's antimicrobial and antiviral activity is strong.
gingerTraditional
Ginger (Zingiber officinale) has millennia of traditional use in TCM, Ayurveda, and global folk medicine for upper respiratory infections, cough, sore throat, and fever. Its gingerols and shogaols provide anti-inflammatory, antiviral, and expectorant activities. Clinical RCT evidence for isolated ginger in URTI is limited, but traditional use is globally consistent.
goldenrodTraditional
Goldenrod is a long-established traditional herb for upper respiratory conditions including nasal catarrh, sinusitis, and sore throat. European herbalism specifically identifies Solidago as an anticatarrhal and diaphoretic for upper respiratory tract infections. It was a primary upper respiratory herb in Europe before Echinacea became widely used.
goldensealTraditional
Goldenseal (Hydrastis canadensis) is a traditional North American herb used by Indigenous peoples and 19th-century herbalists for upper respiratory infections. Its active alkaloid berberine demonstrates antimicrobial activity against common respiratory bacterial pathogens and anti-inflammatory properties relevant to URTI. No modern URTI-specific RCTs exist.
greek mountain teaTraditional
The EMA HMPC formally adopted GMT for traditional use in cough associated with cold. Multiple peer-reviewed reviews document its traditional role across the full spectrum of upper respiratory complaints including cough, rhinitis, sore throat, and nasal congestion. Its antimicrobial, expectorant, and anti-inflammatory properties are biologically relevant.
hedychium spicatumTraditional
H. spicatum is traditionally used for cough, hiccough, and upper respiratory complaints, classified in Ayurveda as 'Shwasahara' and appearing in classical anti-cough formulations. The rhizome is documented in Ayurvedic classics specifically for 'treatment of cough, hiccough, fever and asthma.' Antimicrobial activity of the essential oil provides indirect support.
ho woodTraditional
Ho wood essential oil has been traditionally used to clear and purify the respiratory tract. Its antimicrobial linalool content provides a plausible mechanism for supporting upper respiratory health. This use is documented in French and European aromatherapy traditions.
honey loquat syrupTraditional
Honey loquat syrup (Pi Pa Gao) is a classical Chinese herbal OTC preparation used since the Tang Dynasty for cough, sore throat, and upper respiratory irritation. It combines honey's demulcent properties with loquat leaf's antitussive and expectorant effects. It is among the most widely used OTC herbal cough preparations in China.
honeysuckleTraditional
Honeysuckle (Lonicera japonica) flower is a foundational TCM herb for acute upper respiratory infections corresponding to wind-heat patterns (fever, sore throat, nasal congestion). Its active compounds including chlorogenic acid have antiviral and anti-inflammatory properties. It is a primary ingredient in widely used URTI formulas including Shuanghuanglian and Yin Qiao San.
horehoundTraditional
Horehound is classified by EMA HMPC and German Commission E as a traditional herbal medicine for relief of cough associated with upper respiratory tract colds. Its expectorant, mucolytic, and mild antispasmodic actions underpin this use. Human clinical trial evidence is absent; the EMA's positive opinion is based on plausibility and documented traditional use for ≥30 years.
hyssopTraditional
Hyssop has one of its oldest and best-documented traditional uses in upper respiratory tract conditions including coughs, chest congestion, bronchitis, and the common cold. It is regarded as an expectorant and antispasmodic in classical European, Persian, and Uyghur herbal medicine. The NIH LiverTox database notes its use for respiratory tract infections.
immortelleTraditional
H. italicum EO is traditionally used as an expectorant, decongestant, and for colds and cough across Mediterranean folk medicine. In vitro antibacterial activity against key upper respiratory pathogens has been demonstrated; no human clinical trials exist.
inula racemosaTraditional
I. racemosa has broad traditional documentation for upper respiratory conditions including sinusitis, cough, laryngitis, and nasal congestion across Ayurvedic, Chinese, and Himalayan ethnomedicinal traditions. It is classified as anticatarrhal and expectorant in Ayurvedic pharmacopeias, and is indicated for hiccough and breathing difficulty.
licorice rootTraditional
Licorice root has Commission E approval for catarrhs of the upper respiratory tract and bronchitis. Used for millennia in TCM, Ayurveda, and European medicine for sore throat, cough, and bronchitis, its active glycyrrhizin has antiviral and anti-inflammatory properties, and it serves as a demulcent and expectorant in respiratory formulas.
lobeliaTraditional
Lobelia has extensive documentation as an expectorant, bronchodilator, and respiratory stimulant across Native American, Eclectic, and contemporary herbal traditions. Alpha-lobeline stimulates respiratory chemoreceptors and relaxes bronchial smooth muscle. Despite a plausible pharmacological mechanism, no human clinical trials have validated efficacy for upper respiratory conditions.
mangoTraditional
Mango leaves and bark are traditionally used in Ayurveda and folk medicine for asthma, bronchitis, cough, and throat infections. Mango leaf tea is documented as a traditional remedy to soothe irritated respiratory passages. The bark is described as having tonic effects on mucous membranes.
marjoramTraditional
Marjoram has a long and consistent tradition of use for upper respiratory complaints including coughs, colds, and respiratory infections across Moroccan, Mediterranean, Indian, and European folk medicine. Its expectorant, antimicrobial, and anti-inflammatory properties underpin this use.
marshmallowTraditional
Marshmallow (Althaea officinalis) has European Medicines Agency and Commission E approval for symptomatic treatment of sore throat and associated dry cough, based on well-established traditional use. Its high mucilage content physically coats and soothes inflamed respiratory mucosae. Used in European herbal medicine for over 2000 years for respiratory tract irritation.
mintTraditional
Peppermint is approved by the German Commission E for catarrhs of the upper respiratory tract. Menthol's sensory decongestant effect, combined with the herb's anti-inflammatory and antimicrobial properties, supports traditional use for cough, congestion, and general upper respiratory discomfort.
mulleinTraditional
Mullein (Verbascum thapsus) has been used from antiquity across European, North African, and North American Indigenous traditions for cough, bronchitis, sore throat, and other upper respiratory conditions. Its mucilage provides demulcent effects on respiratory mucosae; its saponins act as expectorants. Human RCT evidence is lacking; evidence is traditional with preclinical support.
mustardTraditional
Mustard's pungent AITC volatiles are traditionally used to support upper respiratory health, acting as a decongestant and mucolytic. The Herbal Reality monograph documents mustard's volatile oils as mucolytic via thinning mucus, and as antimicrobial when excreted through the lungs. These uses span Western folk medicine, Ayurveda, and traditional Chinese medicine.
myrrhTraditional
Myrrh is traditionally used as an expectorant for upper respiratory conditions, including head colds, nasal congestion, bronchial infections, and sore throats. It is documented in multiple traditional systems as an immune stimulant and expectorant during cold and flu season. No dedicated human clinical trials exist.
oreganoTraditional
Oregano is one of the most consistently documented traditional remedies for upper respiratory infections — including colds, flu, and coughs — across Greek, Roman, Chinese, Turkish, and European herbal traditions. Multiple traditional medicine systems document its use as an expectorant and antispasmodic for upper airway conditions. Clinical evidence in humans is lacking but antimicrobial and anti-inflammatory mechanisms provide biological plausibility.
oriental arborvitaeTraditional
P. orientalis is documented in the Chinese Pharmacopoeia and multiple ancient materia medica texts as an antitussive and expectorant medicine, used for coughs, excessive mucus, bronchitis, and related upper respiratory conditions. This is among the most consistently recorded traditional indications.
peppermintTraditional
Peppermint (Mentha x piperita) leaf and oil have Commission E approval for catarrhs of the upper respiratory tract. Menthol activates TRPM8 receptors to reduce perceived nasal congestion, and has mild anesthetic effects on sore throat. EMA has established a monograph for nasal congestion relief in URTI.
perillaTraditional
Perilla has been used in TCM for over 2,000 years as a primary herb for upper respiratory complaints including colds, coughs, and nasal congestion due to wind-cold exposure. The herb appears in multiple classical TCM formulae for these indications. Modern pharmacological studies confirm anti-inflammatory and anti-microbial properties supportive of this traditional use.
picrorhiza kurroaTraditional
P. kurroa is classically used in Ayurvedic and Tibetan medicine for upper respiratory conditions including colds, coughs, and sore throat. Traditional practitioners in Tibet, Nepal, and India widely recommend it for these complaints, and it is a listed traditional use in multiple ethnopharmacological reviews.
pineTraditional
Pine has been used traditionally across many cultures (Native American, ancient Greek, medieval European, Chinese) for upper respiratory conditions. Pine resin, bark tea, and needle steam preparations were used for coughs, colds, bronchitis, and upper respiratory infections. Modern pine extracts appear in cough syrups and lozenges.
platycodonTraditional
Platycodon grandiflorum (balloon flower) root is used in TCM and Korean traditional medicine for cough, sore throat, and phlegm in upper respiratory conditions. Its triterpenoid saponins (platycodin D) have expectorant, anti-inflammatory, and antiviral properties. It appears in multiple classical URTI formulas.
platycodon rootTraditional
Platycodon root (Platycodon grandiflorum; Jie Geng) is a primary TCM expectorant herb used for cough, sore throat, and phlegm associated with upper respiratory infections. Its triterpenoid saponins (platycodin D) provide expectorant, anti-inflammatory, and antiviral activity. It is a component of multiple classical URTI formulas including Sang Ju Yin.
polygala rootTraditional
Polygala root has traditional use in TCM for upper respiratory complaints including colds, cough, and phlegm congestion. It was traditionally used 'for colds and mild respiratory problems' and is listed in the Chinese Pharmacopoeia as an expectorant targeting the Lung meridian.
propolisTraditional
Bee propolis has traditional use across Mediterranean and Eastern European folk medicine for throat infections and upper respiratory conditions. Its polyphenols (CAPE, galangin, quercetin) demonstrate antimicrobial, antiviral, and anti-inflammatory activities. Some clinical evidence supports reduction in URTI incidence and severity in children.
queen of the meadowTraditional
The EMA HMPC monograph and ESCOP recognize queen of the meadow as a traditional herbal product for colds and minor respiratory symptoms. The plant's diaphoretic action supports fever management in colds, and antitussive properties are noted in empirical medicine. No clinical trial evidence exists for respiratory outcomes specifically.
quillajaTraditional
Quillaja saponaria has a long record of traditional use by Andean peoples for various chest and upper respiratory problems. The saponin-rich bark is used as an expectorant and cough remedy. Evidence remains traditional with no controlled clinical trials.
red rootTraditional
Native American traditions specifically document red root use for catarrh, sore throats, fevers, and mucous membrane problems of the upper respiratory tract. The Eclectic tradition further refined this use for pharyngeal and laryngeal complaints. No human clinical trials on upper respiratory outcomes exist.
schizonepetaTraditional
Schizonepeta has been used for over 2,000 years in TCM for upper respiratory conditions including colds, sore throat, nasal congestion, and early respiratory infections. It is categorized as an exterior-releasing herb that supports the body's defense against respiratory pathogens. Evidence is primarily traditional and preclinical.
siler rootTraditional
Siler root's dried root (Radix Saposhnikoviae) is cited in the Chinese Journal of Integrative Medicine review as a traditional Chinese herbal medicine used for respiratory diseases. Its TCM applications include suppressing cough, relieving nasal symptoms, and clearing early-stage respiratory pathogens. Modern evidence is limited to preclinical anti-inflammatory and antiallergic findings.
skullcapTraditional
S. baicalensis is documented in TCM for over 2,000 years for upper respiratory tract infections. Ben Cao Gang Mu lists it for 'upper respiratory tract infections.' The Iroquois used S. lateriflora root infusions for throat clearance. Clinical use in China for acute pulmonary infections continues.
slippery elmTraditional
Slippery elm (Ulmus rubra) inner bark is classified as a safe and effective OTC throat demulcent by the FDA. Its mucopolysaccharide mucilage coats and soothes irritated pharyngeal and upper respiratory mucosae. It has extensive traditional use among North American Indigenous peoples for coughs, sore throats, and respiratory infections.
slippery elm barkTraditional
Slippery elm bark (Ulmus rubra inner bark) is an FDA-recognized safe and effective OTC throat demulcent. Its mucilage physically coats irritated pharyngeal mucosae to soothe sore throat and cough associated with upper respiratory infections. Used for centuries in North American Indigenous medicine for respiratory conditions.
spruceTraditional
Multiple spruce species have documented traditional use across Native American and European folk medicine for upper respiratory infections, including coughs, colds, and throat complaints. The volatile oil and resin provide antiseptic, expectorant, and mucolytic actions in the upper airways. Registered European herbal medicines use Norway spruce for this indication.
stillingiaTraditional
Stillingia was used in Native American medicine and by Eclectic physicians to support the upper respiratory system, including the throat, larynx, and airways. Root chewing and tinctures were employed during winter months for this purpose. No clinical data exist.
tartarian asterTraditional
Tartarian aster root is one of TCM's primary herbs for upper respiratory conditions, used for over 2,000 years for coughs, colds, and bronchial infections. It is listed in the Chinese Pharmacopoeia as an expectorant and antitussive. Preclinical data support antibacterial and antiviral actions against upper respiratory pathogens. No human RCTs for upper respiratory infections as a standalone indication are available.
tylophoraTraditional
Tylophora is a well-established Ayurvedic and folk remedy for upper respiratory complaints including sore throat, cold, cough, and sinusitis. It has been traditionally used in Indian folk medicine for whooping cough, cold, cough, and sore throat, and is described in ethnobotanical literature as a broad respiratory tonic.
watercressTraditional
Watercress has extensive traditional documentation as an expectorant and remedy for coughs, colds, flu, and upper respiratory tract infections across European, Iranian, Moroccan, and Indian medical traditions. It was used by ancient Greek and Roman physicians and remains in documented traditional use. No specific clinical RCT for upper respiratory outcomes exists.
xanthium (cockleburs)Traditional
Beyond nasal conditions, X. strumarium has traditional TCM documentation for chronic bronchitis, and preclinical studies in asthmatic mice models show anti-inflammatory effects of xanthatin via STAT3 and NF-κB inhibition. Use for upper respiratory complaints is one of the plant's most consistent cross-cultural traditional applications.

Other Names

Synopsis

Upper Respiratory Health

Definition, Anatomy, and Clinical Presentation

Causative Agents and Pathogens

Epidemiology and Global Burden

Contributing and Associated Factors

Host and Demographic Factors

Environmental and Exposure Factors

Lifestyle-Related Factors

Nutrients Studied in Relation to Upper Respiratory Health

Vitamin C (Ascorbic Acid)

Traditional Use

Scientific Evidence

Zinc

Traditional Use

Scientific Evidence

Vitamin D

Traditional Use

Scientific Evidence

Herbs and Natural Ingredients Studied in Relation to Upper Respiratory Health

Echinacea Species

Traditional Use

Scientific Evidence

Black Elderberry (Sambucus nigra)

Traditional Use

Scientific Evidence

Quercetin

Traditional Use

Scientific Evidence

Probiotics

Traditional Use

Scientific Evidence

Dietary and Lifestyle Factors

Physical Activity and Exercise

Sleep, Stress, and General Lifestyle

Nutrition and Micronutrient Status

Seasonal and Environmental Dietary Considerations

Summary of Evidence Strength by Intervention

References

Natural Remedies

Ingredients

Stay informed. Stay healthy.